Galibier Capital Management Ltd. Biogen Inc. Transaction History

Galibier Capital Management Ltd.

  • $388 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 02, 2019
SELL
$219.29 - $241.72 $6.4 Million - $7.05 Million
-29,167 Closed
0 $0
Q1 2019

May 10, 2019
SELL
$216.71 - $338.96 $1.13 Million - $1.76 Million
-5,196 Reduced 15.12%
29,167 $6.89 Million
Q4 2018

Feb 12, 2019
BUY
$278.5 - $352.75 $9.57 Million - $12.1 Million
34,363 New
34,363 $10.3 Million

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Galibier Capital Management Ltd. Portfolio

Follow Galibier Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Galibier Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Galibier Capital Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email